Taken together, these data suggest that TGF-β1-mediated miR-29a inhibition may contribute to cholangiocarcinoma cell proliferation and metastasis, which are partly associated with HDAC4-induced EMT. The gene discussed is HDAC4; the disease is cholangiocarcinoma.